SV

Sugumar Vimal

Active Director Director DIN 09018543
DIN 09018543 First appointment Jan 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2021
Shareholding value •••• Premium profile

About Sugumar Vimal

Data last updated:

Sugumar Vimal is a Director at Indigen Biotech Private Limited (since 2021). The company operates in Healthcare. Indigen Biotech Private Limited reported revenue of ₹10 Lakh (FY 2024).

DIN 09018543
Primary Designation Director
Industry Healthcare
First Appointment 04 Jan 2021
Oldest Company Age 5 yrs
Largest company Indigen Biotech Private Limited · ₹10 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indigen Biotech Private Limited U33112TN2021PTC140528
Director04 Jan 20212021₹10 Lakh (FY 2024)Active

Board colleagues of Sugumar Vimal

NameDINCompanyDesignation
Nandhini09018544Indigen Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Indigen Biotech Private Limited
Premium access

Shareholding and investment profile for Sugumar Vimal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sugumar Vimal

Sugumar Vimal currently holds 1 directorship: Indigen Biotech Private Limited (Director, since 04 Jan 2021, revenue ₹10 Lakh (FY 2024)).

Sugumar Vimal was first appointed on 04 Jan 2021 as Director at Indigen Biotech Private Limited.

The current boards of Sugumar Vimal's companies include Nandhini (Indigen Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available